Chemkart Indiaās IPO subscription started on Monday, July 7, 2025, and will close on July 9, 2025, as per the schedule. The price band is set at ā¹236 to ā¹248 per share with a face value of ā¹10.
Chemkart India IPO Subscription Status
Chemkart India IPOĀ subscribed over 1.50x on its Second day till 05.00 PM on 8th July 2025.
- Chemkart India IPO subscription QIB investors portion is 3.41x times, while NII subscribed 1.86x times, and RII investors subscribed 0.26x times.Ā Ā
- The company has received bids for 32,20,800 shares against 21,51,600 Ā shares on offer on the Second day.Ā
- Chemkart India’s IPO subscribed over 1.50x times on day 1.
About Chemkart India IPO
Chemkart India Limited was established in 2015, is one of the leading companies involved in nutritional, Health, and sports supplement products. Its products mostly concentrate on providing health benefits to customers, like nutrition and wellness needs. Chemkart India is based in Mumbai, known to provide a variety of captivated nutritional supplements and components. The company focuses on offering products in 7 categories that include Amino Acids, Health Supplements, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamin. The company caters to the B2B segment, providing its products to companies that use them to manufacture supplements such as sports supplements, health supplements, vitamins, and protein products. They follow a wide range and customer-first approach that is designed to offer grinding, blending, and packaging services at their hygienic facility in Bhiwandi, Mumbai. The company comprises a 28,259.16 sq. ft. warehouse that is loaded for efficient processing, labeling, and sealing of ingredients. The company includes 40 employees as of March 31, 2025.
Chemkart India IPO Company Financial Report
The company reported revenue of ā¹205.46 crores in 2025 against ā¹132.83 crores in 2024. The company reported a profit of ā¹24.26 crores in 2025 against a profit of ā¹14.52 crores in 2024.
Chemkart India IPO GMP
Chemkart Indiaās IPO GMPĀ was ā¹0 as of Tuesday, 8th July. That indicates the IPO is trading at ā¹248 with a ā¹0 premium in the grey market against the issue price of ā¹248.
